Induction and Isolation of Vascular Cells From Human Induced Pluripotent Stem Cells—Brief Report
OBJECTIVE—Induced pluripotent stem (iPS) cells are a novel stem cell population derived from human adult somatic cells through reprogramming using a defined set of transcription factors. Our aim was to determine the features of the directed differentiation of human iPS cells into vascular endothelia...
Saved in:
Published in | Arteriosclerosis, thrombosis, and vascular biology Vol. 29; no. 7; pp. 1100 - 1103 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
American Heart Association, Inc
01.07.2009
Lippincott Williams & Wilkins |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | OBJECTIVE—Induced pluripotent stem (iPS) cells are a novel stem cell population derived from human adult somatic cells through reprogramming using a defined set of transcription factors. Our aim was to determine the features of the directed differentiation of human iPS cells into vascular endothelial cells (ECs) and mural cells (MCs), and to compare that process with human embryonic stem (hES) cells.
METHODS AND RESULTS—We previously established a system for differentiating hES cells into vascular cells. We applied this system to human iPS cells and examined their directed differentiation. After differentiation, TRA1–60 Flk1 cells emerged and divided into VE-cadherin–positive and –negative populations. The former were also positive for CD34, CD31, and eNOS and were consistent with ECs. The latter differentiated into MCs, which expressed smooth muscle α-actin and calponin after further differentiation. The efficiency of the differentiation was comparable to that of human ES cells.
CONCLUSIONS—We succeeded in inducing and isolating human vascular cells from iPS cells and indicate that the properties of human iPS cell differentiation into vascular cells are nearly identical to those of hES cells. This work will contribute to our understanding of human vascular differentiation/development and to the development of vascular regenerative medicine. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1079-5642 1524-4636 |
DOI: | 10.1161/ATVBAHA.108.182162 |